Towards Healthcare

News

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Immuno Cure and PharmaJet Join Forces to Boost HIV Vaccine with Needle-Free Technology
20 June 2025

Immuno Cure and PharmaJet Join Forces to Boost HIV Vaccine with Needle-Free Technology

Immuno Cure and PharmaJet Collaborate to Advance a Vaccine Image Credits: Biospace Announcement Immuno Cure Biotech is a clinical-stage biotechnology group located in the Hong Kong Science Park, is initiating a collaboration with PharmaJet to examine the immunogenicity and safety of HIV therape...

Aptevo Therapeutics Announces $8 Million Share Purchase to Fuel Clinical Growth
20 June 2025

Aptevo Therapeutics Announces $8 Million Share Purchase to Fuel Clinical Growth

Aptevo Therapeutics Buys Shares According to Nasdaq Rules Image Credits: NBC4 Announcement Aptevo Therapeutics Inc. is a clinical-stage biotechnology company that develops novel immune-oncology therapeutics according to its proprietary ADAPTIR-FLEX and ADAPTIR platform technologies has declared...

QIAGEN and GENCURIX Team Up to Develop Digital PCR Oncology Tests
20 June 2025

QIAGEN and GENCURIX Team Up to Develop Digital PCR Oncology Tests

QIAGEN and GENCURIX Partner to Digitize the Healthcare Sector Announcement QIAGEN and GENCURIX partnered to develop oncology assays to perform on the QIAcuityDx platform. A platform popular for its excellent performance in the digital PCR system has been initiated for clinical diagnostics. GENCU...

1Elevan Biopharma Moves Headquarters to Fishers, Indiana with $7 Million Expansion
19 June 2025

1Elevan Biopharma Moves Headquarters to Fishers, Indiana with $7 Million Expansion

1Elevan Shifts its Development to Fishers, Indiana Image Credits: Pharmaceutical Outsourcing Announcement 1Elevan Biopharmaceuticals company has shifted from California to Fishers, Indiana. The company has proclaimed the new headquarters in the Fishers Life Sciences and Innovation Park. The rel...

Invivoscribe’s Subsidiary LabPMM Gets NY State Approval for NPM1 MRD Leukemia Test
19 June 2025

Invivoscribe’s Subsidiary LabPMM Gets NY State Approval for NPM1 MRD Leukemia Test

Invivoscribe’s Subsidiary Received Approval Image Credits: Invivoscribe Announcement Invivoscribe proudly announced its subsidiary’s Laboratory for Personalized Molecular Medicine (LabPMM) approval from the New York State (NYS) for the NPM1 MRD assay. The approval of the subsidiary ...

Sanofi and Novartis Lead 2024 Pharma Buyouts with Record-High Premiums
19 June 2025

Sanofi and Novartis Lead 2024 Pharma Buyouts with Record-High Premiums

Leading Pharmaceutical Companies and their Competitive Negotiations Emerging Negotiations and Bids The acquisition of the company with the highest bid demonstrates the eagerness of the company for a merger, collaboration, and the unification and exchange of developmental progress between the two...

Smith+Nephew Partners with Standard Health to Launch Orthopedic Surgery Center in the UK
19 June 2025

Smith+Nephew Partners with Standard Health to Launch Orthopedic Surgery Center in the UK

Standard Health and Smith+Nephew Announced a Partnership Image Credits: Orthopedic Design and Technology Announcement Smith+Nephew, a leading medical technology company, declared its partnership with Standard Health (www.standardhealth.co.uk). This partnership contributes to the development of ...

Noetik and Agenus Partner to Advance AI-Driven Personalized Cancer Treatment
18 June 2025

Noetik and Agenus Partner to Advance AI-Driven Personalized Cancer Treatment

Noetik and Agenus's Collaboration for Technological Development Announcement Noetik, a global AI-driven spatial and multimodal biology, and Agenus Inc., an immune-oncology innovation, introduced a research collaboration to generate predictive biomarkers of response to Agenus. This will lead to b...

Johnson & Johnson Expands Vision Innovation with TECNIS Odyssey IOL Launch
18 June 2025

Johnson & Johnson Expands Vision Innovation with TECNIS Odyssey IOL Launch

Johnson & Johnson Introduced Innovation in Various Regions Image Credits: Glance by Eyes on Eyecare Announcement Johnson & Johnson, a popular and leading company in eye health, declared an expansion of the portfolio of presbyopia-correcting intraocular lenses with the introduction of th...

Centessa Pharmaceuticals Gets FDA Approval to Begin Trials for New Neurology Drug ORX142
18 June 2025

Centessa Pharmaceuticals Gets FDA Approval to Begin Trials for New Neurology Drug ORX142

Centessa Pharmaceuticals Received US FDA Clearance Image Credits: Seeking Alpha Approval Centessa Pharmaceuticals Plc, a clinical-stage pharmaceutical company, received a US Food and Drug Administration (FDA) IND clearance to initiate a phase 1 clinical study of ORX142 in healthy volunteers. Th...